Drug repurposing of clinically approved drugs to target epithelial-mesenchymal transition using molecular docking approach
Introduction: Epithelial-mesenchymal transition (EMT) is a process of epithelial transformation into mesenchymal cells. It is also a process that contributes to the progression of fibrosis and cancer metastasis. Transforming growth factor-beta (TGF-²), as a potent inducer of EMT, has therefore becam...
| Main Authors: | Chun Hao, Ong, Chau Ling, Tham, Harith, Hanis Hazeera, Firdaus, Nazmi, Ahmad Israf, Daud |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universiti Putra Malaysia Press
2023
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/107414/ http://psasir.upm.edu.my/id/eprint/107414/1/107414.pdf |
Similar Items
Drug repurposing of clinically-approved drugs to target epithelial-mesenchymal transition using in silico analysis
by: Ong, Chun Hao
Published: (2021)
by: Ong, Chun Hao
Published: (2021)
Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches
by: Roney, Miah, et al.
Published: (2025)
by: Roney, Miah, et al.
Published: (2025)
Targeting inflammation in non-small cell lung cancer through drug repurposing
by: Rajasegaran, Thiviyadarshini, et al.
Published: (2023)
by: Rajasegaran, Thiviyadarshini, et al.
Published: (2023)
Predicting repurposed drugs targeting the NS3 protease of dengue virus using machine learning-based QSAR, molecular docking, and molecular dynamics simulations
by: Chongjun, Y., et al.
Published: (2024)
by: Chongjun, Y., et al.
Published: (2024)
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)
by: Elaskalani, O., et al.
Published: (2017)
Blockade of eosinophil-induced bronchial epithelial-mesenchymal transition with a geranyl acetophenone in a coculture model
by: Lee, Yu Zhao, et al.
Published: (2017)
by: Lee, Yu Zhao, et al.
Published: (2017)
Ectopic miRNA network and the crosstalk between different signalling pathways during epithelial–mesenchymal transition and mesenchymal–epithelial transition
by: Razak, Eliza, et al.
Published: (2016)
by: Razak, Eliza, et al.
Published: (2016)
Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells
by: Schwab, R., et al.
Published: (2017)
by: Schwab, R., et al.
Published: (2017)
TGF-β-induced fibrosis: a review on the underlying mechanism and potential therapeutic strategies
by: Ong, Chun Hao, et al.
Published: (2021)
by: Ong, Chun Hao, et al.
Published: (2021)
Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition
by: Hodge, S., et al.
Published: (2009)
by: Hodge, S., et al.
Published: (2009)
Epithelial to mesenchymal transition and eepithelialisation
in wound healing: a review of comparison
by: Abid Nordin,, et al.
Published: (2018)
by: Abid Nordin,, et al.
Published: (2018)
Epithelial-Mesenchymal Transition Occurs in Undifferentiated Basal Airway Epithelial Cells Derived from Normal and Asthmatic Subjects.
by: Hackett, T.-L., et al.
Published: (2009)
by: Hackett, T.-L., et al.
Published: (2009)
Cten promotes epithelial-mesenchymal transition through post-transcriptional stabilization of Snail
by: Thorpe, Hannah, et al.
Published: (2017)
by: Thorpe, Hannah, et al.
Published: (2017)
Rational drug repurposing using sscMap analysis in a HOX-TALE model of leukemia
by: Kettyle, Laura M.J., et al.
Published: (2014)
by: Kettyle, Laura M.J., et al.
Published: (2014)
Discovery of Mycobacterium tuberculosis CYP121 new inhibitor via structure-based drug repurposing
by: El Moudaka, Tarek, et al.
Published: (2022)
by: El Moudaka, Tarek, et al.
Published: (2022)
Epithelial Mesenchymal Transition (EMT) in Bronchiolitis Obliterans Syndrome (BOS) Is Not Restricted to Small Airways
by: Chambers, D.C., et al.
Published: (2009)
by: Chambers, D.C., et al.
Published: (2009)
Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016)
by: Dai, X., et al.
Published: (2016)
Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-β1
by: Hackett, T.L., et al.
Published: (2009)
by: Hackett, T.L., et al.
Published: (2009)
Where Do The Bronchioles Go? Epithelial-Mesenchymal Transition (EMT) Induction And Prevention In Epithelial Cells From Lung Transplant Patients
by: Banerjee, B., et al.
Published: (2011)
by: Banerjee, B., et al.
Published: (2011)
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition
by: Warrier, Sudha, et al.
Published: (2014)
by: Warrier, Sudha, et al.
Published: (2014)
Bone drug targets
by: Dass, Crispin
Published: (2018)
by: Dass, Crispin
Published: (2018)
Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair
by: Moheimani, F., et al.
Published: (2015)
by: Moheimani, F., et al.
Published: (2015)
The protective effects of a synthetic geranyl acetophenone in a cellular model of TNF-α-induced pulmonary epithelial barrier dysfunction
by: Tee, Yee Sim, et al.
Published: (2018)
by: Tee, Yee Sim, et al.
Published: (2018)
SUPPRESSION OF beta-CATENIN/CBP SIGNALING INHIBITS EPITHELIAL-MESENCHYMAL TRANSITION AND MIGRATION OF HUMAN AIRWAY EPITHELIUM
by: Moheimani, F., et al.
Published: (2015)
by: Moheimani, F., et al.
Published: (2015)
Editorial: Current drug targets
by: Sulaiman, Ahmad Hatim, et al.
Published: (2019)
by: Sulaiman, Ahmad Hatim, et al.
Published: (2019)
A synthetic curcuminoid analogue, 2,6-Bis-4-(Hydroxyl-3-Methoxybenzylidine)-Cyclohexanone (BHMC) ameliorates acute airway inflammation of allergic asthma in ovalbumin-sensitized mice
by: Tham, Chau Ling, et al.
Published: (2021)
by: Tham, Chau Ling, et al.
Published: (2021)
Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview
by: Fischer, Peter M.
Published: (2017)
by: Fischer, Peter M.
Published: (2017)
Computational screening of FDA-approved hepatitis c drugs for inhibition of VEGFR2 in liver cancer
by: Roney, Miah, et al.
Published: (2024)
by: Roney, Miah, et al.
Published: (2024)
Drug-targetting of duplex and quadruplex DNA
by: Gavathiotis, Evripidis
Published: (2002)
by: Gavathiotis, Evripidis
Published: (2002)
Kinase targets in CNS drug discovery
by: Gunosewoyo, Hendra, et al.
Published: (2017)
by: Gunosewoyo, Hendra, et al.
Published: (2017)
Differential regulation of LPS-mediated VE-cadherin disruption in human endothelial cells and the underlying signaling pathways: a mini review
by: Chan, Yee Han, et al.
Published: (2020)
by: Chan, Yee Han, et al.
Published: (2020)
Explaining the Bronchiolitis Obliterans Syndrome (BOS) Phenotype-Epithelial-Mesenchymal Transition (EMT) Occurs More Readily in Small Airway Epithelium
by: Banerjee, B., et al.
Published: (2010)
by: Banerjee, B., et al.
Published: (2010)
A signalome screening approach in the autoinflammatory disease TNF Receptor Associated Periodic Syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing
by: Todd, Ian, et al.
Published: (2017)
by: Todd, Ian, et al.
Published: (2017)
Mefenamic acid inhibit transforming growth factor-beta type-1: Repurposing anti-inflammatory drugs in wound healing using in-silico approaches
by: Roney, Miah, et al.
Published: (2023)
by: Roney, Miah, et al.
Published: (2023)
Drug discovery and development: a historical overview, current challenges and perspectives
by: Yu, Chai Xin, et al.
Published: (2024)
by: Yu, Chai Xin, et al.
Published: (2024)
Molecular docking and drug-likeness study of nirmatrelvir as promising drug candidates of dengue virus NS2B-NS3 protease
by: Huq, A.K.M. Moyeenul, et al.
Published: (2023)
by: Huq, A.K.M. Moyeenul, et al.
Published: (2023)
Macromolecules as targeted drugs delivery vehicles: an overview
by: Ali, Yousaf, et al.
Published: (2019)
by: Ali, Yousaf, et al.
Published: (2019)
The therapeutic and psychosocial interaction in enhancing drug targets
by: Musa, Ramli, et al.
Published: (2018)
by: Musa, Ramli, et al.
Published: (2018)
NMR Studies of Nucleic Acids as Drug Targets
by: Gallagher, Cathal T
Published: (2004)
by: Gallagher, Cathal T
Published: (2004)
Polyadenylation as a target for anti-inflammatory drugs
by: Radhi, Masar
Published: (2019)
by: Radhi, Masar
Published: (2019)
Similar Items
-
Drug repurposing of clinically-approved drugs to target epithelial-mesenchymal transition using in silico analysis
by: Ong, Chun Hao
Published: (2021) -
Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches
by: Roney, Miah, et al.
Published: (2025) -
Targeting inflammation in non-small cell lung cancer through drug repurposing
by: Rajasegaran, Thiviyadarshini, et al.
Published: (2023) -
Predicting repurposed drugs targeting the NS3 protease of dengue virus using machine learning-based QSAR, molecular docking, and molecular dynamics simulations
by: Chongjun, Y., et al.
Published: (2024) -
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)